Literature DB >> 21045788

The multiple faces of autoimmune-mediated bone loss.

Georg Schett1, Jean-Pierre David.   

Abstract

Inflammation perturbs normal bone homeostasis and is known to induce bone loss, as it promotes both local cartilage degradation and local and systemic bone destruction by osteoclasts, as well as inhibits bone formation by osteoblasts. Thus, not surprisingly, inflammatory autoimmune diseases often lead to local and/or general bone loss. However, the mechanisms that target the bone in autoimmune disease are complex and diverse, as they range from a direct attack on the bone and cartilage by the immune cells to indirect consequences of disturbances of the systemic control of bone remodeling. This Review discusses current understanding of the mechanisms of autoimmune-mediated bone loss in view of new insight from two new fields of research: osteoimmunology, which analyzes the direct effect of immune cells on bone, and the integrative metabolism approach, which established the existence of neuroendocrine loops that regulate bone remodeling.

Entities:  

Mesh:

Year:  2010        PMID: 21045788     DOI: 10.1038/nrendo.2010.190

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  95 in total

Review 1.  TNF and bone.

Authors:  Jean-Pierre David; Georg Schett
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

2.  Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice.

Authors:  Mark W Hamrick; Mary Anne Della-Fera; Yang-Ho Choi; Catherine Pennington; Diane Hartzell; Clifton A Baile
Journal:  J Bone Miner Res       Date:  2005-01-18       Impact factor: 6.741

Review 3.  Osteoimmunology and the effects of the immune system on bone.

Authors:  Hiroshi Takayanagi
Journal:  Nat Rev Rheumatol       Date:  2009-11-03       Impact factor: 20.543

4.  CTLA-4 directly inhibits osteoclast formation.

Authors:  R Axmann; S Herman; M Zaiss; S Franz; K Polzer; J Zwerina; M Herrmann; J Smolen; G Schett
Journal:  Ann Rheum Dis       Date:  2008-01-18       Impact factor: 19.103

5.  Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway.

Authors:  Reiko Hanada; Hitoshi Teranishi; James Todd Pearson; Mamoru Kurokawa; Hiroshi Hosoda; Nobuhiro Fukushima; Yoshihiko Fukue; Ryota Serino; Hiroaki Fujihara; Yoichi Ueta; Masahito Ikawa; Masaru Okabe; Noboru Murakami; Mikiyasu Shirai; Hironobu Yoshimatsu; Kenji Kangawa; Masayasu Kojima
Journal:  Nat Med       Date:  2004-09-26       Impact factor: 53.440

Review 6.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

Review 7.  Bone and metabolism: a complex crosstalk.

Authors:  Liesbet Lieben; Filip Callewaert; Roger Bouillon
Journal:  Horm Res       Date:  2009-01-21

8.  Treg cells suppress osteoclast formation: a new link between the immune system and bone.

Authors:  Mario M Zaiss; Roland Axmann; Jochen Zwerina; Karin Polzer; Eva Gückel; Alla Skapenko; Hendrik Schulze-Koops; Nikki Horwood; Andrew Cope; Georg Schett
Journal:  Arthritis Rheum       Date:  2007-12

9.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Authors:  B R Wong; R Josien; S Y Lee; B Sauter; H L Li; R M Steinman; Y Choi
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

View more
  49 in total

1.  Unlocking the bone: Fcγ-receptors and antibody glycosylation are keys to connecting bone homeostasis to humoral immunity.

Authors:  Michaela Seeling; Falk Nimmerjahn
Journal:  Ann Transl Med       Date:  2015-07

Review 2.  The balance of tissue repair and remodeling in chronic arthritis.

Authors:  Rik Lories
Journal:  Nat Rev Rheumatol       Date:  2011-10-18       Impact factor: 20.543

Review 3.  Harnessing and modulating inflammation in strategies for bone regeneration.

Authors:  Paschalia M Mountziaris; Patrick P Spicer; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2011-06-30       Impact factor: 6.389

Review 4.  Effects of anti-tumor necrosis factor α agents on bone.

Authors:  Vivian K Kawai; C Michael Stein; Daniel S Perrien; Marie R Griffin
Journal:  Curr Opin Rheumatol       Date:  2012-09       Impact factor: 5.006

Review 5.  Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts.

Authors:  Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

6.  Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis.

Authors:  Y Liu; L Wang; S Liu; D Liu; C Chen; X Xu; X Chen; S Shi
Journal:  J Dent Res       Date:  2014-09-24       Impact factor: 6.116

7.  [Interaction between bone, fat and insulin].

Authors:  J Luther; J-P David
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

8.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

Authors:  Julie J Kim-Chang; Lorena Wilson; Cliburn Chan; Bernard Fischer; Guglielmo Venturi; Maureen M Goodenow; Grace Aldrovandi; Thomas J Weber; John W Sleasman
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-27       Impact factor: 2.205

9.  Association between calcaneus quantitative ultrasound (QUS) parameters and thyroid status in middle-aged and elderly Chinese men with euthyroidism: a population-based cross-sectional study.

Authors:  Yun Shi; Min Sun; Zhixiao Wang; Qi Fu; Mengdie Cao; Zhenxin Zhu; Chuchen Meng; Jia Mao; Yu Duan; Wei Tang; Xiaoping Huang; Jieli Lu; Yufang Bi; Guang Ning; Wei He; Tao Yang
Journal:  Endocrine       Date:  2014-01-24       Impact factor: 3.633

10.  Technetium-99 conjugated with methylene diphosphonate ameliorates ovariectomy-induced osteoporotic phenotype without causing osteonecrosis in the jaw.

Authors:  Yinghua Zhao; Lei Wang; Yi Liu; Kentaro Akiyama; Chider Chen; Ikiru Atsuta; Tao Zhou; Xiaohong Duan; Yan Jin; Songtao Shi
Journal:  Calcif Tissue Int       Date:  2012-10-12       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.